ArticlePathogens (Basel, Switzerland)2026
National Cross-Sectional Study Assessing the Positivity Rate and Clinical Manifestations of Human Bocavirus Respiratory Infections Among Hospitalized Children Under 5 Years of Age in Jordan.
Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Human bocavirus (HBoV) is an important respiratory pathogen in young children, but recent data from Jordan are limited. This study assessed the positivity rate, epidemiological profile, clinical manifestations, and predictors of HBoV infection among hospitalized children aged <5 years in Jordan. In this national multicenter cross-sectional study, 1000 children aged <5 years admitted with acute respiratory infection to four hospitals in Jordan between November 2022 and March 2023 were included. Nasopharyngeal specimens were tested for HBoV, and demographic, clinical, and hospitalization data were analyzed using descriptive statistics and logistic regression. HBoV was detected in 48/1000 children (4.8%), with the highest positivity in January 2023 (15.5%). Fever (100%), cough (100%), rhinorrhea (56.3%), respiratory crackles (58.3%), and breathlessness (47.9%) were the most frequent manifestations. Pneumothorax/atelectasis was more frequent in HBoV-positive than HBoV-negative children (2.1% vs. 0.2%;
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.